- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00763594
Linköping University Relational and Interpersonal Psychotherapy Project (LURIPP)
Randomized Controlled Trial of Interpersonal and Brief Relational Psychotherapy for Major Depressive Disorder.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Interventions Interpersonal Psychotherapy (IPT; Klerman et. al., 1984) is an evidence-based, time-limited treatment originally developed for treating Major Depressive Disorder, although it has been extended and developed for Bulimia Nervosa and recently also for Post-Traumatic Stress Disorder. The treatment is structured and focuses on relieving depressive symptoms by targeting interpersonal problems in the patients' current life situation. In the first four sessions an interpersonal problem area is identified that is asssumed to maintain the patient's depression and this problem is agreed upon as a therapy focus. Four types of focus areas are used in IPT: grief, role transitions, conflicts, and interpersonal deficits. In the middle phase of therapy the agreed upon focus area is worked with in a problem-solving fashion, and the patient is also encouraged to seek interpersonal support from his or her environment. IPT has been established as an evidence-based treatment for Major Depression (Roth & Fonagy, 2005), and a recent meta-analysis concluded that it was slightly superior to other established treatments for MDD including Cognitive Behavior Therapy (Cuijpers, van Straaten, Andersson & van Oppen, 2008).
Brief Relational Therapy (BRT; Safran & Muran, 2000) is a relatively new version of Short-Term Psychodynamic Psychotherapy, based on relational psychoanalytic theory in combination with research on processes of rupture and repair of the therapeutic alliance. The therapeutic alliance, operationalized as the positive bond between patient and therapist in combination with agreement on tasks and goals of treatment, is the single most robust predictor of good outcome in psychotherapy research (Lambert & Ogles, 2004). BRT was developed to help patients who had previously failed in psychotherapeutic treatment(s), presumably because of trouble in establishing a working therapeutic alliance with their therapist(s). Therapists are trained to be highly attentive to the therapeutic relationship and to signs of ruptures in the alliance, and to use self-disclosure and meta-communication about ruptures in order to repair the therapy alliance and at the same time help patients to develop a generalized capacity for observing self and others (mentalization). BRT has shown preliminary evidence for efficacy with patients who are at risk of negative outcome in psychotherapy (Safran, Muran, Samstag & Winston, 2005) and with patients diagnosed with DSM-IV axis II personality disorders (Muran, Safran, Samstag & Winston, 2005). A specific manual for BRT in Major Depressive Disorder is currently under development (Holmqvist, in preparation).
Both treatments consist of 16 therapy sessions which are all video-taped for adherence checks. The same therapists will provide both treatments, in randomized order.
Objectives The objectives of the study are to compare the new treatment BRT with the established treatment IPT in the alleviation of Major Depressive Disorder. The hypothesis of the trial is that BRT will be superior for patients who have more difficulty establishing a therapeutic alliance, while IPT will be superior for patients with less difficulty establishing a therapeutic alliance. Previous research indicates that baseline self-critical perfectionism negatively predicts outcome in IPT as well as several other brief psychotherapeutic treatments for depression, and that this is because self-critical perfectionism will cause problems in the therapeutic alliance (Luyten, Corveleyn & Blatt, 2005). The primary hypothesis is thus that baseline self-cricial perfectionism moderates the relationship between treatment and outcome. Secondary exploratory objectives are to conduct in depth process research on the mechanisms of change in these treatments, as well as interaction effects between treatment modality and other patient characteristics.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Linköping, Sweden, SE-581 83
- Linköping University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Major Depressive Disorder (DSM-IV)
- Hamilton Depression Rating Scale (17-item version) score 20 or greater
Exclusion Criteria:
- Any psychotic disorder
- Substance abuse
- Organic brain disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: IPT
Interpersonal Psychotherapy for Major Depressive Disorder
|
16 weeks of psychodynamically informed and therapy alliance focussed psychotherapy adapted for treating Major Depressive Disorder.
Other Names:
16 weeks of Interpersonal Psychotherapy for Major Depressive Disorder
|
EXPERIMENTAL: BRT
Brief Relational Therapy adapted for treatment of Major Depressive Disorder
|
16 weeks of psychodynamically informed and therapy alliance focussed psychotherapy adapted for treating Major Depressive Disorder.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hamilton Depression Rating Scale, 17 item version
Time Frame: Change from before treatment to after termination (16 weeks)
|
The primary outcome is depression severity immediately after termination, controlling for depression severity immediately before treatment.
Depression severity is measured using the 17 item version of the Hamilton Depression Rating Scale.
|
Change from before treatment to after termination (16 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Patient Health Questionnaire - 9
Time Frame: Change from before treatment to after termination (16 weeks)
|
Change from before treatment to after termination (16 weeks)
|
Inventory of Interpersonal Problems
Time Frame: Change from before treatment to after termination (16 weeks)
|
Change from before treatment to after termination (16 weeks)
|
Quality of Life Inventory
Time Frame: Change from before treatment to after termination (16 weeks)
|
Change from before treatment to after termination (16 weeks)
|
Depressive Experiences Questionnaire
Time Frame: Change from before treatment to after termination (16 weeks)
|
Change from before treatment to after termination (16 weeks)
|
Outcome Questionnaire - 45
Time Frame: Change from before treatment to after termination (16 weeks)
|
Change from before treatment to after termination (16 weeks)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Fredrik Falkenström, MA, Sörmland County Council, Linköping University
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- M59-08
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Depressive Disorder
-
Shalvata Mental Health CenterUnknownMAjor Depressive DisorderIsrael
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDDIndia
-
Gangnam Severance HospitalCompletedMajor Depressive Disorder(MDD)Korea, Republic of
-
University College, LondonCompletedUnipolar Major Depressive DisorderUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...Fondo de Investigacion SanitariaUnknown
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDD)India
-
Repurposed Therapeutics, Inc.Unknown
-
GlaxoSmithKlineCompletedMajor Depressive Disorder (MDD)United States
-
AccexibleRecruitingMajor Depressive Disorder (MDD)Spain
Clinical Trials on Brief Relational Therapy
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University Hospital, AngersCompleted
-
Columbia UniversityEinhorn CollaborativeSuspendedChild Development | Primary Prevention | Disruptive Behavior | Emotional ConnectionUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI)CompletedDepression | Cancer | Anxiety | Unspecified Adult Solid Tumor, Protocol Specific | Cognitive Behavioral TherapyUnited States
-
University of California, DavisActive, not recruitingBehavior, HealthUnited States
-
Universitat Oberta de CatalunyaNot yet recruitingCouples | Relational Problems
-
Dartmouth-Hitchcock Medical CenterNational Institute of Mental Health (NIMH)CompletedStress Disorders, Post-TraumaticUnited States
-
Assistance Publique - Hôpitaux de ParisGIRCI IDFNot yet recruitingVentilation TherapyFrance
-
University of California, IrvineNational Institute on Minority Health and Health Disparities (NIMHD); Emory...Recruiting
-
Ankara UniversityCompleted